checkAd
    Startseite > Aktien > Roche Holding > Nachrichten
    Roche Holding Aktie
    31,33
     
    USD
    +0,10 %
    +0,03 USD
    Letzter Kurs 02:10:00 Nasdaq OTC
    ISIN: US7711951043 · WKN: 891106 · SYM: RHHBY · Schweiz

    Neueste Nachrichten

    FDA grants Priority Review to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
    29.05.24 · globenewswire · Roche Holding
    FDA Grants Priority Review to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
    29.05.24 · Business Wire (engl.) · Roche Holding
    Changes to the Roche Enlarged Corporate Executive Committee
    27.05.24 · globenewswire · Roche Holding
    Wechsel in der erweiterten Konzernleitung von Roche
    27.05.24 · globenewswire · Roche Holding
    Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk
    22.05.24 · globenewswire · Roche Holding
    FDA Grants Breakthrough Therapy Designation to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer with a PIK3CA Mutation
    21.05.24 · Business Wire (engl.) · Roche Holding
    FDA grants Breakthrough Therapy Designation to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
    21.05.24 · globenewswire · Roche Holding
    Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People With Obesity
    16.05.24 · Business Wire (engl.) · Roche Holding
    [Ad hoc announcement pursuant to Art. 53 LR] Roche reports positive Phase I results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity
    16.05.24 · globenewswire · Roche Holding
    Roche announces FDA approval of one of the first HPV self-collection solutions in the U.S., expanding access and screening options to help eliminate cervical cancer
    15.05.24 · globenewswire · Roche Holding
    [Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
    24.04.24 · globenewswire · Roche Holding
    [Ad hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der Roche-Gruppe steigen im ersten Quartal um 2% (CER); beide Divisionen Pharma und Diagnostics wachsen im hohen einstelligen Bereich ohne COVID-19-Produkte
    24.04.24 · globenewswire · Roche Holding